Stay updated on Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous revision. This reflects a newer page build without changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-05T14:20:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a newer version of the page content or UI is in place, with no changes to the study information itself.
    Difference
    0.1%
    Check dated 2026-06-28T08:30:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    New navigation/help items were added: How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and the revision tag Revision: v3.6.0. The navigation item Intervention / Treatment was removed.
    Difference
    0.5%
    Check dated 2026-06-13T17:53:17.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new page revision v3.5.5 was published, replacing the previous v3.5.4. This reflects a minor update to the page's metadata or formatting rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-06T14:21:36.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added and the previous tag v3.5.3 was removed, updating the page's version label in the site metadata.
    Difference
    0.1%
    Check dated 2026-05-15T22:47:35.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page footer revision/version was incremented from **v3.5.2** to **v3.5.3**, reflecting a minor technical update to the site presentation rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.